Polymorphisms of glutathione-S-transferase M1, T1, P1 and the risk of prostate cancer: a case-control study
Open Access
- 5 March 2009
- journal article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 28 (1) , 32
Abstract
It has been suggested that polymorphisms in glutathione-S-transferases (GST) could predispose to prostate cancer through a heritable deficiency in detoxification pathways for environmental carcinogens. Yet, studies linking GST polymorphism and prostate cancer have so far failed to unambiguously establish this relation in patients. A retrospective study on healthy, unrelated subjects was conducted in order to estimate the population GST genotype frequencies in the Slovak population of men and compare our results with already published data (GSEC project-Genetic Susceptibility to Environmental Carcinogens). A further aim of the study was to evaluate polymorphisms in GST also in patients with prostate cancer in order to compare the evaluated proportions with those found in the control subjects. We determined the GST genotypes in 228 healthy, unrelated subjects who attended regular prostate cancer screening between May 2005 and June 2007 and in 129 histologically verified prostate cancer patients. Analysis for the GST gene polymorphisms was performed by PCR and PCR-RFLP. We found that the GST frequencies are not significantly different from those estimated in a European multicentre study or from the results published by another group in Slovakia. Our results suggest that Val/Val genotype of GSTP1 gene could modulate the risk of prostate cancer, even if this association did not reach statistical significance. We did not observe significantly different crude rates of the GSTM1 and GSTT1 null genotypes in the men diagnosed with prostate cancer and those in the control group. Understanding the contribution of GST gene polymorphisms and their interactions with other relevant factors may improve screening diagnostic assays for prostate cancer. We therefore discuss issues of study feasibility, study design, and statistical power, which should be taken into account in planning further trials.Keywords
This publication has 30 references indexed in Scilit:
- Low risk prostate cancer in men under age 65: The case for definitive treatmentUrologic Oncology: Seminars and Original Investigations, 2007
- Polymorphisms in the glutathione S-transferaseM1,T1, andP1genes and prostate cancer prognosisThe Prostate, 2006
- Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese populationJournal of Cancer Research and Clinical Oncology, 2004
- Genetic polymorphism of glutathione S‐transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern IndiaBJU International, 2004
- Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancerCancer Genetics and Cytogenetics, 2004
- LONG-TERM SURVIVAL PROBABILITY IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER: A CASE-CONTROL, PROPENSITY MODELING STUDY STRATIFIED BY RACE, AGE, TREATMENT AND COMORBIDITIESJournal of Urology, 2004
- Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S‐transferases GSTM1, GSTM3, and GSTT1 genetic polymorphismsThe Prostate, 2003
- Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention studyEuropean Journal Of Cancer Prevention, 2003
- Biostatistical AnalysisEcology, 1996
- Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defectThe Lancet, 1996